Literature DB >> 18082343

Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology.

Ryo Suzuki1, Tomoko Takizawa, Yoichi Negishi, Naoki Utoguchi, Kazuo Maruyama.   

Abstract

From the viewpoint of safety, non-viral vector systems represent an attractive gene delivery system for gene therapy. However, the transfection efficiency of non-viral vectors in vivo is generally very low. Previously, it was reported that microbubbles, utilized as imaging agents for diagnostic echocardiography, could promote gene delivery into cells when combined with ultrasound exposure. We therefore developed novel liposomal bubbles (Bubble liposomes) containing the lipid nanobubbles of perfluoropropane which is used as ultrasound imaging agent. These Bubble liposomes were smaller in diameter than conventional microbubbles and induced cavitation upon exposure to ultrasound. These results suggested that cavitation of these Bubble liposomes could be an efficient approach for delivering plasmid DNA into cells. In addition, in in vivo gene delivery, the combination of Bubble liposomes and ultrasound provided more effective gene delivery than conventional lipofection methods, further suggesting that Bubble liposomes could be effective as a non-viral vector system in in vivo gene delivery. In this review, we discuss the characteristics of Bubble liposomes and their potential utility as a gene delivery tool in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18082343     DOI: 10.1016/j.ijpharm.2007.10.034

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  23 in total

Review 1.  Ultrasound imaging beyond the vasculature with new generation contrast agents.

Authors:  Reshani H Perera; Christopher Hernandez; Haoyan Zhou; Pavan Kota; Alan Burke; Agata A Exner
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-01-08

2.  Fluorescent microscope system to monitor real-time interactions between focused ultrasound, echogenic drug delivery vehicles, and live cell membranes.

Authors:  Stuart Ibsen; Michael Benchimol; Sadik Esener
Journal:  Ultrasonics       Date:  2012-05-28       Impact factor: 2.890

Review 3.  Lipid and polymeric carrier-mediated nucleic acid delivery.

Authors:  Lin Zhu; Ram I Mahato
Journal:  Expert Opin Drug Deliv       Date:  2010-10       Impact factor: 6.648

Review 4.  Nucleic acid delivery with microbubbles and ultrasound.

Authors:  Joshua J Rychak; Alexander L Klibanov
Journal:  Adv Drug Deliv Rev       Date:  2014-01-31       Impact factor: 15.470

5.  Characterization of the dynamic activities of a population of microbubbles driven by pulsed ultrasound exposure in sonoporation.

Authors:  Zhenzhen Fan; Di Chen; Cheri X Deng
Journal:  Ultrasound Med Biol       Date:  2014-01-30       Impact factor: 2.998

6.  Delivery of an angiogenic gene into ischemic muscle by novel bubble liposomes followed by ultrasound exposure.

Authors:  Yoichi Negishi; Keiko Matsuo; Yoko Endo-Takahashi; Kentaro Suzuki; Yuuki Matsuki; Norio Takagi; Ryo Suzuki; Kazuo Maruyama; Yukihiko Aramaki
Journal:  Pharm Res       Date:  2010-10-08       Impact factor: 4.200

Review 7.  Gene therapy for ischemic heart disease.

Authors:  Madhav Lavu; Susheel Gundewar; David J Lefer
Journal:  J Mol Cell Cardiol       Date:  2010-06-26       Impact factor: 5.000

Review 8.  Physical approaches for nucleic acid delivery to liver.

Authors:  Kenya Kamimura; Dexi Liu
Journal:  AAPS J       Date:  2008-12-13       Impact factor: 4.009

9.  Intracellular delivery and calcium transients generated in sonoporation facilitated by microbubbles.

Authors:  Z Fan; R E Kumon; J Park; C X Deng
Journal:  J Control Release       Date:  2009-10-07       Impact factor: 9.776

10.  Effective intraperitoneal gene transfection system using nanobubbles and ultrasound irradiation.

Authors:  Koyo Nishimura; Shintaro Fumoto; Yuki Fuchigami; Masayori Hagimori; Kazuo Maruyama; Shigeru Kawakami
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.